Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma

Pulmonary Pharmacology and Therapeutics

Volumn 19, Issue 2, 2006, Pages 139-147

  Balanag, V M ^a   Yunus, F ^b   Yang, P C ^c   Jorup, C ^d  

^a Lung Center of the Philippines   (Philippines)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Budesonide formoterol; Reliever medication; Symbicort

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; PREDNISOLONE; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; BRADYCARDIA; BREATHING RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EXTRASYSTOLE; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; HYPERTENSION; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ASTHMA; BUDESONIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ELECTROCARDIOGRAPHY; ETHANOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS;

EID: 30144442800     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.04.009     Document Type: Article

References (36)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (updated 2004). National Institutes of Health [NIH] publication No. 02-3659. Accessible at www.ginasthma.org.
2. British Thoracic Society British guidelines on the management of asthma Thorax 58 Suppl 1 2003 1 94
3. R.A. Pauwels, C.-G. Löfdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, and P.J. Barnes Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 1997 1405 1411
4. P.M. O'Byrne, P.J. Barnes, R. Rodriguez-Roisin, E. Runnerstrom, T. Sandstrom, and K. Svensson Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial Am J Respir Crit Care Med 164 2001 1392 1397
5. ® (budesonide and formoterol in a single inhaler) improves asthma control in adults: a randomised controlled study Eur Respir J 18 2001 262 268
6. L. Rosenhall, J.H. Heinig, A. Lindqvist, J. Leegaard, E. Ståhl, and P.B. Bergqvist Budesonide/formoterol (Symbicort) is well tolerated and effective in patients with moderate persistent asthma Int J Clin Pract 56 2002 427 433
7. A. Tal, G. Simon, J.H. Vermeulen, V. Petru, N. Cobos, and M.L. Everard Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma Pediatr Pulmonol 34 2002 342 350
8. R. Buhl, J.P.H.M. Creemers, V. Vondra, N.A. Martelli, I.P. Naya, and T. Ekström Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma Respir Med 97 2003 323 330
9. E.D. Bateman, T.A. Bantje, M.J. Gomes, M.G. Toumbis, R.M. Huber, and I. Naya Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma Am J Respir Med 2 2003 275 281
10. U.G. Lalloo, J. Malolepszy, D. Kozma, K. Krofta, J. Ankerst, and B. Johansen Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroids in adults with mild-to-moderate asthma Chest 123 2003 1480 1487
11. M. Palmqvist, G. Persson, L. Lazer, J. Rosenborg, P. Larsson, and J. Lötvall Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency Eur Respir J 10 1997 2484 2489
12. ® Respir Med 92 1998 1017 1021
13. ®) showed as rapid an onset of action as salbutamol given by a pMDI Respir Med 94 2000 607 611
14. J.A. van Noord, J.J. Smeets, J.A.M. Raaijmakers, A.M. Bommer, and F.P.V. Maesen Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action Eur Respir J 9 1996 1684 1688
15. J. Lötvall, G. Persson, P. Larssen, C. Mardell, and J. Rosenborg Tolerability of inhaled high doses of formoterol and salbutamol in asthmatic patients maintained on twice-daily formoterol 12 μg (9 μg delivered) Eur Respir J 10 Suppl 25 1997 103s [abstract P0699]
16. J. Rosenborg, T. Bengtsson, P. Larsson, A. Blomgren, G. Persson, and J. Lötvall Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics Eur J Clin Pharmacol 56 2000 363 370
17. ® at cumulative dose of 90 μg in patients with acute bronchial asthma Eur Respir J 18 2001 928 934
18. W. Boonsawat, S. Charoenratanakul, C. Pothirat, K. Sawanyawisuth, T. Seeraramroongruang, and T. Bengtsson Formoterol (OXIS) turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma Respir Med 97 2003 1067 1074
19. A.E. Tattersfield, C.G. Löfdahl, D.S. Postma, A. Eivindson, A.G.M. Schreurs, and A. Rasidakis Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial Lancet 357 2001 257 261
20. R.A. Pauwels, M.R. Sears, M. Campbell, C. Villasante, S. Huang, A. Lindh, and The RELIEF Study Investigators and the Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial Eur Respir J 22 2003 787 794
21. M. Palmqvist, P. Arvidsson, O. Beckman, S. Peterson, and J. Lötvall Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers Pulm Pharmacol Ther 14 2001 29 34
22. H.J. van der Woude, M. Boorsma, P.B.F. Bergqvist, T.H. Winter, and R. Aalbers Budesonide/formoterol in a singe inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction Pulm Pharmacol Ther 17 2004 89 95
23. R. Ellul-Micallef, E. Hansson, and S.A. Johansson Budesonide: a new corticosteroid in bronchial asthma Eur J Respir Dis 61 1980 167 173
24. R. Ellul-Micallef, and S.A. Johansson Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide Br J Clin Pharmacol 15 1983 419 422
25. T. Engel, A. Dirksen, J.H. Heinig, N.H. Nielsen, B. Weeke, and S.Å. Johansson Single-dose inhaled budesonide in subjects with chronic asthma Allergy 46 1991 547 553
26. J. Ankerst, G. Persson, and E. Weibull Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma Pulm Pharmacol Ther 16 2003 147 151
27. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 1987 225 244
28. Ph.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report of the working party: standardisation of lung function tests. European Community for Steel and Coal. Official statement of the European Respiratory Society Eur Respir J 16 Suppl 16 1993 5 40
29. 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration Allergy 44 1989 264 271
30. K.F. Rabe, R. Jörres, D. Nowak, N. Behr, and H. Magnussen Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma Am Rev Respir Dis 147 1993 1436 1441
31. I. Aziz, A.M. Wilson, and B.J. Lipworth Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults Chest 118 2000 1049 1058
32. B. Volovitz, L. Bentur, Y. Finkelstein, Y. Mansour, S. Shalitin, and M. Nussinovitch Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone J Allergy Clin Immunol 102 1998 605 609
33. T.W. Higgenbottam, J. Britton, D. Lawrence, C.K. Connolly, N.K. Harrison, and H.M. Eastham Comparison of nebulised budesonide and prednisolone in severe asthma exacerbation in adults Biodrugs 14 2000 247 254
34. M.O. Turner, A. Patel, S. Ginsburg, and J.M. FitzGerald Bronchodilator delivery in acute airflow obstruction. A meta-analysis Arch Intern Med 157 1997 1736 1744
35. Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software; 2003.
36. J. Rosenborg, P. Larsson, Z. Rott, C. Böcskei, M. Poczi, and G. Juhász Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients Respir Med 96 2002 412 417